ABY CHERUVATHOOR POULOSE

Dr. ABY CHERUVATHOOR POULOSE

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
GZGiorgio Zoppellaro
Giorgio Zoppellaro
Ioannis KonidakisIoannis Konidakis
Ioannis Konidakis
ESEfthymis Serpetzoglou
Efthymis Serpetzoglou
Emmanuel StratakisEmmanuel Stratakis
Emmanuel Stratakis
Radek ZbořilRadek Zbořil
Radek Zbořil
Reduction of nitroaromatics to the corresponding amines is a key process in the fine and bulk chemicals industry to produce polymers, pharmaceuticals, agrochemicals and dyes. However, their effective and selective reduction requires high temperatures and pressurized hydrogen and involves noble metal-based catalysts. Here we report on an earth-abundant, plasmonic nano-photocatalyst, with an excellent reaction rate towards the selective hydrogenation of nitroaromatics. With solar light as the only energy input, the chalcopyrite catalyst operates through the combined action of hot holes and photothermal effects. Ultrafast laser transient absorption and light-induced electron paramagnetic resonance spectroscopies have unveiled the energy matching of the hot holes in the valence band of the catalyst with the frontier orbitals of the hydrogen and electron donor, via a transient coordination intermediate. Consequently, the reusable and sustainable copper-iron-sulfide (CuFeS2) catalyst delivers previously unattainable turnover frequencies, even in large-scale reactions, while the cost-normalized production rate stands an order of magnitude above the state of the art.

14 June 2011 in Journal of Fluorescence
Verified
Journal Article
Closed access
PDF file
RNRemya Nair
Remya Nair
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
YNYutaka Nagaoka
Yutaka Nagaoka
YYYasuhiko Yoshida
Yasuhiko Yoshida
TMToru Maekawa
Toru Maekawa
SKSakthi Kumar
Sakthi Kumar

1 February 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SRSreejesh Poikavila Raghunathan
Sreejesh Poikavila Raghunathan
SNSona Narayanan
Sona Narayanan
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
RJRani Joseph
Rani Joseph

1 January 2013 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Sreejith RaveendranSreejith Raveendran
Sreejith Raveendran
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
YYYasuhiko Yoshida
Yasuhiko Yoshida
TMToru Maekawa
Toru Maekawa
SKSakthi Kumar
Sakthi Kumar

1 November 2008 in Solar Energy Materials and Solar Cells
Verified
Journal Article
Closed access
KSKalarical Janardhanan Sreeram
Kalarical Janardhanan Sreeram
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
BNBalachandran Unni Nair
Balachandran Unni Nair
TRThirumalachari Ramasami
Thirumalachari Ramasami

3 March 2015 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ABY CHERUVATHOOR POULOSEABY CHERUVATHOOR POULOSE
ABY CHERUVATHOOR POULOSE
SVSrivani Veeranarayanan
Srivani Veeranarayanan
SMSheikh Mohamed Mohamed
Sheikh Mohamed Mohamed
YNYutaka Nagaoka
Yutaka Nagaoka
RARebeca Romero Aburto
Rebeca Romero Aburto
SKSakthi Kumar
Sakthi Kumar
A size and shape tuned, multifunctional metal chalcogenide, Cu2S-based nanotheranostic agent is developed for trimodal imaging and multimodal therapeutics against brain cancer cells. This theranostic agent was highly efficient in optical, photoacoustic and X-ray contrast imaging systems. The folate targeted NIR-responsive photothermal ablation in synergism with the chemotherapeutic action of doxorubicin proved to be a rapid precision guided cancer-killing module. The multi-stimuli, i.e., pH-, thermo- and photo-responsive drug release behavior of the nanoconjugates opens up a wider corridor for on-demand triggered drug administration. The simple synthesis protocol, combined with the multitudes of interesting features packed into a single nanoformulation, clearly demonstrates the competing role of this Cu2S nanosystem in future cancer treatment strategies.